NL7905775A - Pyrimidonderivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. - Google Patents
Pyrimidonderivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. Download PDFInfo
- Publication number
- NL7905775A NL7905775A NL7905775A NL7905775A NL7905775A NL 7905775 A NL7905775 A NL 7905775A NL 7905775 A NL7905775 A NL 7905775A NL 7905775 A NL7905775 A NL 7905775A NL 7905775 A NL7905775 A NL 7905775A
- Authority
- NL
- Netherlands
- Prior art keywords
- methyl
- formula
- pyrimidinone
- amino
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7831153 | 1978-07-26 | ||
| GB7831153 | 1978-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7905775A true NL7905775A (nl) | 1980-01-29 |
Family
ID=10498669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7905775A NL7905775A (nl) | 1978-07-26 | 1979-07-25 | Pyrimidonderivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4524071A (de) |
| JP (1) | JPS5540670A (de) |
| AU (1) | AU534744B2 (de) |
| BE (1) | BE877889A (de) |
| CH (1) | CH642952A5 (de) |
| DE (1) | DE2928842A1 (de) |
| DK (1) | DK310779A (de) |
| ES (1) | ES482869A1 (de) |
| FR (1) | FR2433527A1 (de) |
| GB (1) | GB2030979B (de) |
| IT (1) | IT1117778B (de) |
| NL (1) | NL7905775A (de) |
| SE (1) | SE7906372L (de) |
| ZA (1) | ZA793443B (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN151188B (de) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| CA1155842A (en) * | 1980-03-29 | 1983-10-25 | Thomas H. Brown | Compounds |
| US4607107A (en) * | 1980-10-01 | 1986-08-19 | Smith Kline & French Laboratories Ltd. | (4-aminoalkyl-2-pyridyl alkyl)guanidines |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| US4620001A (en) * | 1981-02-06 | 1986-10-28 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
| US4352933A (en) * | 1981-02-06 | 1982-10-05 | Smithkline Beckman Corporation | Chemical methods and intermediates for preparing substituted pyrimidinones |
| JPS58110681A (ja) * | 1981-12-23 | 1983-07-01 | Showa Denko Kk | 純鉄の錆取り方法 |
| IT1153066B (it) * | 1982-11-18 | 1987-01-14 | Mentedison S P A | Derivati del pirimidin-4-one ad attivita' erbicida |
| PT77623B (en) * | 1982-11-25 | 1986-03-19 | Smith Kline French Lab | Process for the preparation of a small class of histamine h2-antagonists |
| GB8311443D0 (en) * | 1983-04-27 | 1983-06-02 | Smith Kline French Lab | Chemical compounds |
| GB8318638D0 (en) * | 1983-07-09 | 1983-08-10 | Smith Kline French Lab | Chemical compounds |
| GB8320505D0 (en) * | 1983-07-29 | 1983-09-01 | Smith Kline French Lab | Chemical compounds |
| GB8332091D0 (en) * | 1983-12-01 | 1984-01-11 | Smith Kline French Lab | Chemical compounds |
| GB8421427D0 (en) * | 1984-08-23 | 1984-09-26 | Smith Kline French Lab | Chemical compounds |
| JO1410B1 (en) * | 1984-11-03 | 1986-11-30 | سميث كلاين اند فرينش لابوراتوريز ليمتد | Vehicles |
| JPS61155373A (ja) * | 1984-12-28 | 1986-07-15 | Yamanouchi Pharmaceut Co Ltd | 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法 |
| JPH02101170A (ja) * | 1988-10-07 | 1990-04-12 | Mitsubishi Electric Corp | アルミニウム合金表面の前処理方法 |
| JPH04323392A (ja) * | 1991-04-19 | 1992-11-12 | Nkk Corp | チタン材の酸洗処理方法 |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338169A (en) * | 1971-03-09 | 1973-11-21 | Smith Kline French Lab | Ureas thioureas and guanidines |
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| US4145546A (en) * | 1975-10-02 | 1979-03-20 | Smith Kline & French Laboratories Limited | 4-Pyrimidone compounds |
| IN146736B (de) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab | |
| US4154834A (en) * | 1975-12-29 | 1979-05-15 | Smith Kline & French Laboratories Limited | Substituted isocytosines having histamine H2 -antagonist activity |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| IN151188B (de) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab |
-
1979
- 1979-07-10 ZA ZA793443A patent/ZA793443B/xx unknown
- 1979-07-17 DE DE19792928842 patent/DE2928842A1/de not_active Ceased
- 1979-07-17 US US06/058,256 patent/US4524071A/en not_active Expired - Lifetime
- 1979-07-23 DK DK310779A patent/DK310779A/da not_active Application Discontinuation
- 1979-07-24 IT IT49849/79A patent/IT1117778B/it active
- 1979-07-24 FR FR7919037A patent/FR2433527A1/fr active Granted
- 1979-07-25 GB GB7925879A patent/GB2030979B/en not_active Expired
- 1979-07-25 SE SE7906372A patent/SE7906372L/xx not_active Application Discontinuation
- 1979-07-25 BE BE0/196449A patent/BE877889A/xx not_active IP Right Cessation
- 1979-07-25 CH CH691679A patent/CH642952A5/de not_active IP Right Cessation
- 1979-07-25 JP JP9484379A patent/JPS5540670A/ja active Pending
- 1979-07-25 NL NL7905775A patent/NL7905775A/nl not_active Application Discontinuation
- 1979-07-26 ES ES482869A patent/ES482869A1/es not_active Expired
- 1979-07-26 AU AU49249/79A patent/AU534744B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| SE7906372L (sv) | 1980-01-28 |
| DE2928842A1 (de) | 1980-02-14 |
| ES482869A1 (es) | 1980-09-01 |
| AU534744B2 (en) | 1984-02-16 |
| IT1117778B (it) | 1986-02-24 |
| DK310779A (da) | 1980-02-29 |
| ZA793443B (en) | 1980-12-31 |
| BE877889A (fr) | 1979-11-16 |
| GB2030979A (en) | 1980-04-16 |
| FR2433527B1 (de) | 1982-10-15 |
| FR2433527A1 (fr) | 1980-03-14 |
| AU4924979A (en) | 1980-01-31 |
| GB2030979B (en) | 1983-03-02 |
| CH642952A5 (de) | 1984-05-15 |
| IT7949849A0 (it) | 1979-07-24 |
| US4524071A (en) | 1985-06-18 |
| JPS5540670A (en) | 1980-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL7905775A (nl) | Pyrimidonderivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten. | |
| NL192454C (nl) | N,N'- digesubstitueerde ureum-, thioureum-, guanidine- en diaminoetheenderivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze derivaten bevatten. | |
| US7504410B2 (en) | Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents | |
| AU593278B2 (en) | Pharmaceutically active 2-thiomethyl-substituted-1,4- dihydropyridines | |
| SK4796A3 (en) | Tri-substituted imidazoles, manufacturing process thereof, pharmaceutical agent containing them and their use | |
| DK162389B (da) | Analogifremgangsmaade til fremstilling af 2-oe4-oe(4,4-dialkyl-2,6-piperidindion-1-yl)butylaa-1-piperazinylaapyrimidiner | |
| NO162384B (no) | Analogifremgangsmaate til fremstilling av 1-hetero-aryl-4-(2,5-pyrrolidinion-1-yl)-alkyl)piperazinderivater. | |
| NO158419B (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner. | |
| EP0112704B1 (de) | Pyridinderivate | |
| JPS609755B2 (ja) | 異項環式化合物 | |
| Danel et al. | Anti-HIV active naphthyl analogues of HEPT and DABO | |
| JP2008509182A5 (de) | ||
| FI91754C (fi) | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi | |
| DK165367B (da) | Imidazolylalkylguanidinderivater, fremgangsmaade til fremstilling heraf samt laegemidler indeholdende disse forbindelser | |
| IE53348B1 (en) | Pyrimidinone derivatives and pharmaceutical compositions containing them | |
| CS210684B2 (en) | Manufacturing process of 2-aminopyrimidones | |
| CZ20032224A3 (en) | 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry | |
| US5326879A (en) | Indole derivatives | |
| KR840001775B1 (ko) | 헤테로 사이클릭 유도체의 제조방법 | |
| KR870001197A (ko) | 환상 아미드 및 이미드의 노인정신병학적 디아지닐피페리딘 유도체 | |
| US4940712A (en) | Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors | |
| DK160500B (da) | Analogifremgangsmaade til fremstilling af 3-thiomethylpyridinderivater | |
| US4395553A (en) | Chemical compounds | |
| CA1336516C (en) | Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines | |
| KR880002209B1 (ko) | 치환된 3,4-디아미노-1,2,5-티아디아졸류 및 그의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |